CORCencora

Health care · Drug Wholesale · NYSE

Cencora is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. 10-K, Item 1

Employees: 51,000
Headquarters: Conshohocken, PA
CEO: Robert P. Mauch
Next results: around Feb 3, 2027

Compare with peers → Embed

The numbers COR said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.

Target	What the company said	Reported	Result
Diluted EPS (company-defined) Fiscal 2027	Given $19.40 to $19.75 release 2026-11-04	–	No standard number
The company's words Fiscal 2027 Adjusted Diluted EPS Expected to be in the Range of $19.40 to $19.75, reflecting growth of 8 percent to 10 percent release 2026-11-04
Diluted EPS (company-defined) Fiscal 2026	Given $17.45 to $17.75 release 2026-02-04 Raised $17.65 to $17.90 release 2026-05-06 Raised $17.75 to $17.95 release 2026-08-05	–	No standard number
The company's words Adjusted Diluted EPS Guidance Range Reaffirmed at $17.45 to $17.75 for Fiscal 2026 release 2026-02-04 Adjusted Diluted EPS Guidance Range Raised to $17.65 to $17.90 for Fiscal 2026 release 2026-05-06 Adjusted Diluted EPS Guidance Range Raised to $17.75 to $17.95 for Fiscal 2026 release 2026-08-05
Diluted EPS (company-defined) Fiscal 2025 (ended 2025-09-30)	Given $15.25 to $15.55 release 2025-02-05 Raised $15.70 to $15.95 release 2025-05-07 Raised $15.85 to $16.00 release 2025-08-06	–	No standard number
The company's words Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55 for Fiscal 2025 release 2025-02-05 Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95 for Fiscal 2025 release 2025-05-07 Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00 for Fiscal 2025 release 2025-08-06
Diluted EPS (company-defined) Fiscal 2024 (ended 2024-09-30)	Given $13.25 to $13.50 release 2024-01-31 Raised $13.30 to $13.50 release 2024-05-01 Raised $13.55 to $13.65 release 2024-07-31	–	No standard number
The company's words Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50 for Fiscal 2024 release 2024-01-31 Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50 for Fiscal 2024 release 2024-05-01 Adjusted Diluted EPS Guidance Range Raised to $13.55 to $13.65 for Fiscal 2024 release 2024-07-31

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (14 releases since 2023-11-02), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Work on COR in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/COR/export.csv") into a cell.